论文部分内容阅读
目的:探讨分析慢性阻塞性肺疾病合并呼吸衰竭的治疗方法及其临床疗效。方法:回顾性分析2013年6月至2014年7月本院接治的68例慢性阻塞性肺疾病合并呼吸衰竭患者的临床记录资料。结果:治疗后治疗组的动脉血氧分压(Pa O2)、p H值均高于对照组,动脉血二氧化碳分压(Pa CO2)低于对照组,治疗后的呼吸频率(RR)、心率(HR)也均明显低于对照组,差异均具有统计学意义(P<0.05)。结论:盐酸氨溴索联合左氧氟沙星治疗慢性阻塞性肺疾病合并呼吸衰竭的临床疗效显著。
Objective: To investigate the treatment of chronic obstructive pulmonary disease combined with respiratory failure and its clinical efficacy. Methods: Clinical data of 68 COPD patients with respiratory failure who were treated in our hospital from June 2013 to July 2014 were analyzed retrospectively. Results: After treatment, PaO2 and pH values in the treatment group were higher than those in the control group. The PaCO2 in the arterial blood was lower than that in the control group. Respiratory rate (RR), heart rate (HR) were also significantly lower than the control group, the difference was statistically significant (P <0.05). Conclusion: The clinical efficacy of ambroxol combined with levofloxacin in the treatment of chronic obstructive pulmonary disease with respiratory failure is significant.